RevitaLash Cosmetics Announces Road to $10 Million Goal in Support of Breast Cancer Initiatives
VENTURA, Calif., April 15, 2025 /PRNewswire/ -- RevitaLash® Cosmetics, globally recognized for…
Arkade Developers Supports 263 Cancer Patients Through Care Per Sq Ft Initiative, Collects 122 Blood Units in Strong Partnership with Tata Memorial Hospital and Sajjan Jain Trust
MUMBAI, India, April 7, 2025 /PRNewswire/ -- Arkade Developers Limited, through its…
NCCN 2025 Annual Conference Illustrates the Critical Impact of Cancer Research on Improving Lives
The National Comprehensive Cancer Network celebrated its 30th anniversary with a series…
FDA approves Novartis radioligand therapy Pluvicto for earlier use before chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer
Ad hoc announcement pursuant to Art. 53 LR New indication approximately triples…
Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary
March 25, 2025 07:00 ET | Source: Predictive Oncology Inc. Company successfully…
Oxford BioTherapeutics Enters into a Strategic Collaboration with Roche to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer
March 19, 2025 04:00 ET | Source: Oxford BioTherapeutics Collaboration leverages OBT’s…
Primo Partners with ABX to Bring PB01 Closer to Taiwans Prostate Cancer Market
TAIPEI, Taiwan, March 19, 2025 (GLOBE NEWSWIRE) -- In response to the…
Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025
- The late-breaking oral presentation at SGO 2025 highlights consistent response rates…
Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Womens Cancer
March 15, 2025 11:25 ET | Source: ZENTALIS PHARMACEUTICALS Azenosertib median duration…
Dr Massimo Cristofanilli, MD Joins Datar Cancer Genetics as Strategic Advisor
NEW YORK and LONDON and MUNICH and NEW DELHI, Feb. 11, 2025…
